Showing 1 - 10 results of 10 for search 'Enrico Ricevuto', query time: 0.04s Refine Results
  1. 1
    Toxicity Syndromes, Patient-Related Clinical Indicator of Toxicity Burden Induced by Intensive Triplet Chemotherapy-Based Regimens in Gastrointestinal Cancers With Metastatic Disease

    Toxicity Syndromes, Patient-Related Clinical Indicator of Toxicity Burden Induced by Intensive Triplet Chemotherapy-Based Regimens in Gastrointestinal Cancers With Metastatic Disea... by Gemma Bruera, Gemma Bruera, Enrico Ricevuto, Enrico Ricevuto

    Published 2020-02-01
    Get full text
    Article
  2. 2
    Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient With KRAS Mutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemotherapy

    Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient With KRAS Mutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemothe... by Gemma Bruera, Gemma Bruera, Antonio D'Andrilli, Maurizio Simmaco, Stefano Guadagni, Stefano Guadagni, Erino Angelo Rendina, Enrico Ricevuto, Enrico Ricevuto

    Published 2020-08-01
    Get full text
    Article
  3. 3
    Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review

    Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review by Silvia De Rocco, Jasmine Di Biasi, Ilaria Fantasia, Sara Tabacco, Enrico Ricevuto, Pierpaolo Palumbo, Ilenia Imbergamo, Manuela Ludovisi, Maurizio Guido

    Published 2024-02-01
    Get full text
    Article
  4. 4
    Plasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional Implications.

    Plasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional Implications. by Domenica Scumaci, Laura Tammè, Claudia Vincenza Fiumara, Giusi Pappaianni, Antonio Concolino, Emanuela Leone, Maria Concetta Faniello, Barbara Quaresima, Enrico Ricevuto, Francesco Saverio Costanzo, Giovanni Cuda

    Published 2015-01-01
    Get full text
    Article
  5. 5
    Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice

    Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line... by Gemma Bruera, Antonio Giuliani, Lucia Romano, Alessandro Chiominto, Alessandra Di Sibio, Stefania Mastropietro, Pierluigi Cosenza, Enrico Ricevuto, Mario Schietroma, Francesco Carlei, on behalf of Oncology Network ASL1 Abruzzo

    Published 2019-10-01
    Get full text
    Article
  6. 6
    Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A

    Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternativ... by Stefano Guadagni, Antonietta Rosella Farina, Lucia Annamaria Cappabianca, Michela Sebastiano, Rita Maccarone, Veronica Zelli, Marco Clementi, Alessandro Chiominto, Gemma Bruera, Enrico Ricevuto, Giammaria Fiorentini, Donatella Sarti, Andrew Reay Mackay

    Published 2020-11-01
    Get full text
    Article
  7. 7
    Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases

    Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recu... by Stefano Guadagni, Francesco Masedu, Giammaria Fiorentini, Donatella Sarti, Caterina Fiorentini, Veronica Guadagni, Panagiotis Apostolou, Ioannis Papasotiriou, Panagiotis Parsonidis, Marco Valenti, Enrico Ricevuto, Gemma Bruera, Antonietta R. Farina, Andrew R. Mackay, Marco Clementi

    Published 2022-06-01
    Get full text
    Article
  8. 8
    <i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories

    <i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories by Ettore Capoluongo, Nicla La Verde, Massimo Barberis, Maria Angela Bella, Fiamma Buttitta, Paola Carrera, Nicoletta Colombo, Laura Cortesi, Maurizio Genuardi, Massimo Gion, Valentina Guarneri, Domenica Lorusso, Antonio Marchetti, Paolo Marchetti, Nicola Normanno, Barbara Pasini, Matilde Pensabene, Sandro Pignata, Paolo Radice, Enrico Ricevuto, Anna Sapino, Pierosandro Tagliaferri, Pierfrancesco Tassone, Chiara Trevisiol, Mauro Truini, Liliana Varesco, Antonio Russo, Stefania Gori

    Published 2019-10-01
    Get full text
    Article
  9. 9
    Axitinib after Sunitinib in metastatic renal cancer: preliminary results from Italian “Real-Word” SAX study

    Axitinib after Sunitinib in metastatic renal cancer: preliminary results from Italian “Real-Word” SAX study by Carmine D'Aniello, Maria Giuseppa Vitale, Azzurra Farnese, Lorenzo Calvetti, Maria Maddalena Laterza, Carla Cavaliere, Chiara Della Pepa, Vincenza Conteduca, Anna Crispo, Ferdinando De Vita, Francesco Grillone, Enrico Ricevuto, Michele De Tursi, Rocco De Vivo, Marilena Di Napoli, Sabrina Chiara Cecere, Gelsomina Iovane, Alfonso Amore, Raffaele Piscitelli, Giuseppe Quarto, Salvatore Pisconti, Gennaro Ciliberto, Piera Maiolino, Paolo Muto, Sisto Perdona, Massimiliano Berretta, Luca Galli, Giacomo Cartenì, Ugo De Giorgi, Sandro Pignata, GAETANO FACCHINI, Sabrina Rossetti

    Published 2016-09-01
    Get full text
    Article
  10. 10
    Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

    Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results by Gaetano Facchini, Sabrina Rossetti, Massimiliano Berretta, Carla Cavaliere, Sarah Scagliarini, Maria Giuseppa Vitale, Chiara Ciccarese, Giuseppe Di Lorenzo, Erica Palesandro, Vincenza Conteduca, Umberto Basso, Emanuele Naglieri, Azzurra Farnesi, Michele Aieta, Nicolò Borsellino, Leonardo La Torre, Gelsomina Iovane, Lucia Bonomi, Donatello Gasparro, Enrico Ricevuto, Michele De Tursi, Rocco De Vivo, Giovanni Lo Re, Francesco Grillone, Paolo Marchetti, Ferdinando De Vita, Claudio Scavelli, Claudio Sini, Salvatore Pisconti, Anna Crispo, Vittorio Gebbia, Antonio Maestri, Luca Galli, Ugo De Giorgi, Roberto Iacovelli, Carlo Buonerba, Giacomo Cartenì, Carmine D’Aniello

    Published 2019-08-01
    Get full text
    Article

Search Tools: